Meniscectomy (Shaving of Cartilage) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Meniscectomy — commonly referred to as shaving of cartilage — is a surgical procedure in which damaged or torn portions of the meniscus (the C-shaped fibrocartilaginous discs within the knee joint) are trimmed, smoothed, or removed. The goal is to eliminate mechanical symptoms — locking, catching, and pain — caused by displaced or unstable meniscal tissue while preserving as much functional meniscus as possible.

The menisci serve critical biomechanical functions: they distribute load across the tibiofemoral joint, absorb shock, provide joint stability, and facilitate lubrication. Meniscal tears are among the most common musculoskeletal injuries, with an estimated incidence of 60–70 per 100,000 population annually. They occur through acute trauma (sports injuries, twisting mechanisms) or degenerative wear (particularly in middle-aged and older adults).

Performed arthroscopically through small keyhole incisions using a camera and powered shaver instruments, meniscectomy has largely replaced open surgical approaches. It is one of the most frequently performed orthopedic procedures globally — approximately 700,000 arthroscopic meniscectomies are performed annually in the United States alone. However, contemporary evidence emphasises the importance of meniscal preservation, and the procedure is increasingly reserved for mechanical tears with clear symptomatic correlation.

Meniscectomy addresses specific types of meniscal pathology causing mechanical symptoms and joint dysfunction:

• Traumatic Meniscal Tears (Acute): Bucket-handle tears (longitudinal vertical tears that can displace into the joint causing locking), radial tears, horizontal cleavage tears, and complex multi-pattern tears in young active patients that are irreparable.
• Degenerative Meniscal Tears: Horizontal or complex tears occurring through age-related fibrocartilage degeneration in patients over 40, often associated with early osteoarthritis. The role of surgery versus rehabilitation in this group is nuanced (see Alternatives).
• Flap Tears: A portion of torn meniscus that folds over and mechanically impinges within the joint, causing pain and restricted motion.
• Discoid Meniscus: An anatomical variant in which the meniscus is abnormally disc-shaped rather than C-shaped, prone to tearing and causing symptoms. Partial meniscectomy is performed to create a more normal shape (saucerisation).
• Failed Meniscal Repair: Previously repaired meniscal tears that re-tear or fail to heal may require secondary partial meniscectomy to remove the unstable tissue.
• Meniscal Cysts: Parameniscal cysts associated with horizontal cleavage tears can be decompressed via partial meniscectomy of the underlying tear.

Appropriate patient selection is critical for satisfactory outcomes from meniscectomy. Not all meniscal tears require surgery. Eligibility criteria include:

• Mechanical symptoms: Locking, catching, giving way, or joint-line pain that correlates anatomically with the tear on MRI and clinical examination. McMurray, Thessaly, and Apley tests assist clinical diagnosis.
• MRI-confirmed tear with symptom correlation: Symptomatic tears on MRI are distinguished from incidental findings (common in asymptomatic adults over 45).
• Irreparable tear morphology: Radial tears, degenerative horizontal tears, and complex tears in avascular zones are not amenable to suture repair; meniscectomy is preferred. Vertical longitudinal tears in the vascular (red) zone of younger patients should be repaired when possible.
• Failed conservative management: Inadequate improvement after 6–12 weeks of physiotherapy, activity modification, NSAIDs, and intra-articular injections — specifically for degenerative tears.
• Absence of severe osteoarthritis: Advanced knee OA (Kellgren-Lawrence grade 3–4) significantly reduces the benefit of meniscectomy. In such cases, total knee arthroplasty may be more appropriate.
• Active patients with acute tears: Young athletes with acute bucket-handle tears causing locked knees or significant functional limitation are early surgical candidates, ideally within 3–6 weeks of injury.

Meniscectomy is performed arthroscopically in virtually all contemporary cases. The surgeon makes two or three small portal incisions (5 mm each) around the knee, introduces a 4 mm arthroscope connected to a high-definition camera, and uses a combination of hand instruments and a motorised shaver/radiofrequency device:

Partial Meniscectomy

The current standard of care where tissue is removed. The torn, unstable fragment is excised back to a stable rim of meniscal tissue. All unstable edges are trimmed to a smooth, congruent contour using the powered shaver. The goal is to preserve the maximum amount of meniscal tissue possible, as residual meniscal function is biomechanically superior to total loss.

Total Meniscectomy

Complete removal of the entire meniscus. Largely abandoned for degenerative and most traumatic tears due to demonstrated long-term progression to knee osteoarthritis (70–80% develop significant OA within 15–20 years). Reserved only for situations where the entire meniscus is irreparably destroyed.

Subtotal Meniscectomy

Resection of the majority of the meniscus while preserving the peripheral rim. Still carries significant long-term OA risk and is avoided when partial resection is feasible.

Concurrent Procedures

Arthroscopy permits simultaneous assessment and treatment of additional intra-articular pathology: chondral lesions (microfracture, chondroplasty), ACL or PCL pathology, loose body removal, and synovitis debridement. Lateral release may be added for patellar maltracking.

When performed for the right indications, meniscectomy provides rapid and meaningful symptomatic relief:

• Rapid pain relief: Most patients experience significant reduction in mechanical knee pain within days to weeks of surgery. Studies report 75–85% short-term satisfaction rates in patients with genuine mechanical tears.
• Resolution of mechanical symptoms: Locking and catching due to displaced meniscal fragments resolve immediately after removal of the offending tissue.
• Fast return to activity: As a day-case procedure, most patients walk the same day. Return to light activity at 2 weeks, full sport at 4–12 weeks depending on extent of resection.
• Reduced swelling and stiffness: Elimination of inflamed, torn tissue reduces reactive synovitis and joint effusion.
• Minimal surgical trauma: Three 5 mm incisions result in negligible scarring, no muscle division, and low infection risk.
• Joint assessment opportunity: Arthroscopy provides definitive diagnosis of any coexisting chondral or ligamentous pathology that may require simultaneous or staged treatment.

Meniscectomy is generally a low-risk procedure, but several important complications and long-term concerns must be discussed:

• Accelerated knee osteoarthritis: The most significant long-term risk. The meniscus bears 40–70% of load transmission across the knee. Meniscal tissue loss increases peak contact stress on articular cartilage. Studies show 20–25% of partial meniscectomy patients develop knee OA within 10 years; this rises to 70–80% after total meniscectomy over 20 years.
• Re-tear: Residual meniscal tissue may tear again, particularly with high-demand activity or in the presence of ligamentous laxity. Revision meniscectomy is then required.
• Infection: Septic arthritis occurs in <0.1–0.5% of arthroscopic procedures but is a serious complication requiring joint washout and antibiotics.
• Deep vein thrombosis (DVT) / Pulmonary embolism (PE): Risk is low for brief knee arthroscopy but increased with longer procedures, obesity, or immobility. Chemical thromboprophylaxis is recommended per guidelines for higher-risk patients.
• Nerve or vessel injury: Injury to the popliteal vessels or common peroneal nerve is rare (<0.1%) but potentially catastrophic. Portal placement anatomy must be respected.
• Persistent pain or poor response: 15–20% of patients do not achieve satisfactory relief, particularly those with coexisting OA where the tear is likely incidental to the degenerative process.
• Stiffness (arthrofibrosis): Excessive scar tissue formation is uncommon after arthroscopic meniscectomy but may require physiotherapy or manipulation under anaesthesia.

Recovery from arthroscopic partial meniscectomy is rapid compared to open surgery:

Day of Surgery

The procedure takes 20–45 minutes under general, spinal, or regional anaesthesia. Patients are discharged home within 2–4 hours with crutches (if needed), analgesics (paracetamol, NSAIDs), and a wound dressing. Weight bearing is usually permitted immediately as tolerated.

Days 1–7

Portal wounds are kept dry for 5–7 days. Crutches are typically discontinued by day 3–5. Ice and elevation reduce swelling. Gentle quadriceps activation and range-of-motion exercises begin immediately under physiotherapy guidance.

Weeks 2–4

Return to desk work at 1–2 weeks. Progressive physiotherapy includes strengthening, proprioception, and neuromuscular training. Cycling on a stationary bike is introduced at 2 weeks. Running begins at 3–4 weeks if swelling and strength are adequate.

Weeks 4–12 (Sport Return)

Return-to-sport criteria include: full range of motion, quadriceps strength ≥80% of contralateral leg (isokinetic testing), and single-leg hop symmetry. Most recreational athletes return to sport at 4–6 weeks; high-performance athletes at 8–12 weeks depending on the extent of resection. Sport-specific training under physiotherapy supervision is mandatory before competition return.

Long-Term Follow-Up

Patients with partial meniscectomy should understand the elevated OA risk and adopt protective strategies: maintaining healthy BMI, strengthening quadriceps and hamstrings, low-impact exercise (cycling, swimming), and consideration of future meniscal allograft transplantation if significant meniscal loss occurred in a young patient.

Arthroscopic meniscectomy is highly cost-variable based on healthcare system, hospital tier, and whether additional procedures are performed concurrently:

• United States: $5,000–$15,000 (outpatient surgical centre); up to $25,000 in hospital settings
• United Kingdom: £3,000–£8,000 (private); available on NHS with waiting times typically 3–6 months
• India: $1,000–$3,000 — High-volume arthroscopy programmes in Delhi, Mumbai, Hyderabad with international-standard implants
• Thailand: $2,000–$5,000 — Excellent orthopaedic departments in Bangkok's JCI-accredited hospitals
• Turkey: $1,500–$4,000 — Cost-effective destination with fellowship-trained arthroscopic surgeons
• Germany: $5,000–$12,000 — Premium standard with advanced arthroscopic technology and comprehensive rehabilitation

Cost drivers include: general vs. regional anaesthesia, concurrent procedures (ACL repair, chondral treatment), hospital vs. ambulatory surgical centre, implant brands (radiofrequency devices), post-operative physiotherapy, and travel logistics for international patients. Patients should ensure the treating surgeon is arthroscopy-fellowship trained and that high-definition arthroscopic equipment (HD camera, motorised shaver) is available.

Significant high-quality evidence now supports non-surgical management for degenerative meniscal tears. The following alternatives should be tried before meniscectomy, particularly in patients over 40:

• Structured physiotherapy (Exercise therapy): The METEOR trial (2018, NEJM) and Danish Cohort (2016) found that arthroscopic partial meniscectomy offered no significant benefit over sham surgery or physiotherapy alone in patients with degenerative meniscal tears and no mechanical symptoms. A 12-week structured exercise programme (quadriceps strengthening, neuromuscular control) is now first-line for degenerative tears.
• NSAIDs and analgesics: Short-term use of oral NSAIDs (ibuprofen, naproxen, diclofenac) reduces inflammation and pain. Topical NSAIDs (diclofenac gel) have fewer systemic effects for localised knee pain.
• Intra-articular corticosteroid injection: Provides 4–12 weeks of significant pain relief and reduced swelling, allowing physiotherapy. Particularly effective when synovitis is prominent.
• Intra-articular hyaluronic acid (viscosupplementation): Modest evidence supports pain reduction in early OA with meniscal degeneration. Effect is more durable than corticosteroids in some patients.
• Platelet-Rich Plasma (PRP): Emerging evidence suggests intra-articular PRP may improve symptoms in degenerative meniscal tears by promoting local healing. Not yet standard of care but increasingly offered at specialist centres.
• Meniscal repair: For appropriate tears in young patients (vertical longitudinal tears in the vascular zone, <40 years, acute <6 weeks), meniscal suture repair preserves tissue and should always be preferred over excision when technically feasible.
• Meniscal allograft transplantation: For young patients who have previously undergone total or near-total meniscectomy and experience significant joint pain. Cadaveric meniscal tissue is implanted to restore load distribution. Specialist procedure with good intermediate-term outcomes.